Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)
Hong Kong · Delayed Price · Currency is HKD 4.500
0.00 (0.00%)
May 7, 2026, 3:43 PM HKT
HKG:2563 Market Cap
HKG:2563 has a market cap or net worth of 1.64 billion as of May 7, 2026. Its market cap has decreased by -72.73% in one year.
Market Cap
1.64B
Enterprise Value
1.13B
Revenue
37.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.50
Market Cap Chart
Since October 31, 2024, HKG:2563's market cap has decreased from 7.58B to 1.64B, a decrease of -78.37%. That is a compound annual growth rate of -63.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 1.64B | -7.98% |
| Dec 31, 2025 | 1.78B | -75.18% |
| Dec 31, 2024 | 7.18B | -5.29% |
| Oct 31, 2024 | 7.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 2.30B |
| Frontage Holdings | 1.99B |
| SinoMab BioScience | 1.98B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.91B |
| Mabpharm | 1.86B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.72B |
| Cutia Therapeutics | 1.66B |
| Zhaoke Ophthalmology | 1.62B |